Medicinal Chemicals and Botanical Products - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Medicinal industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Medicinal Chemicals and Botanical Products - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Medicinal Chemicals and Botanical Products
Corporate Insider Buy Sell Ratio (Insider Count) - Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-02-08 USNA / USANA Health Sciences, Inc. 4 IIEKKING G DOUG F - Taxes D 21.34 -2,746
2026-02-08 USNA / USANA Health Sciences, Inc. 4 Benedict Peter F - Taxes D 21.34 -401
2026-02-08 USNA / USANA Health Sciences, Inc. 4 Guest Kevin F - Taxes D 21.34 -1,875
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Guest Kevin M - Exercise D 6,601
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Neidig Brent M - Exercise D 1,401
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Foukas Joshua M - Exercise D 1,571
2026-02-07 USNA / USANA Health Sciences, Inc. 4 IIEKKING G DOUG M - Exercise D 2,231
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Jones Paul A. M - Exercise D 1,372
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Noot Walter M - Exercise D 1,705
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Benedict Peter M - Exercise D 631
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Benedict Peter F - Taxes D 21.34 -219
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Guest Kevin F - Taxes D 21.34 -2,796
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Noot Walter F - Taxes D 21.34 -813
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Jones Paul A. F - Taxes D 21.34 -476
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Neidig Brent F - Taxes D 21.34 -696
2026-02-07 USNA / USANA Health Sciences, Inc. 4 Foukas Joshua F - Taxes D 21.34 -749
2026-02-07 USNA / USANA Health Sciences, Inc. 4 IIEKKING G DOUG F - Taxes D 21.34 -1,612
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Noot Walter M - Exercise D 3,375
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Neidig Brent M - Exercise D 2,219
2026-02-06 USNA / USANA Health Sciences, Inc. 4 IIEKKING G DOUG M - Exercise D 3,532
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Jones Paul A. M - Exercise D 2,174
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Benedict Peter M - Exercise D 1,000
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Foukas Joshua M - Exercise D 3,111
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Guest Kevin M - Exercise D 12,061
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Guest Kevin F - Taxes D 21.34 -5,345
2026-02-06 USNA / USANA Health Sciences, Inc. 4 IIEKKING G DOUG F - Taxes D 21.34 -2,567
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Noot Walter F - Taxes D 21.34 -1,609
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Neidig Brent F - Taxes D 21.34 -1,102
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Foukas Joshua F - Taxes D 21.34 -1,483
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Jones Paul A. F - Taxes D 21.34 -754
2026-02-06 USNA / USANA Health Sciences, Inc. 4 Benedict Peter F - Taxes D 21.34 -347
2026-02-03 DFTX / Definium Therapeutics, Inc. 4 Roberts Brandi A - Award D 150,000
2026-02-03 DFTX / Definium Therapeutics, Inc. 4 Karlin Dan A - Award D 150,000
2026-02-03 DFTX / Definium Therapeutics, Inc. 4 Wiley Matthew T. A - Award D 115,000
2026-02-03 DFTX / Definium Therapeutics, Inc. 4 Sullivan Mark A - Award D 125,000
2026-02-03 DFTX / Definium Therapeutics, Inc. 4 Barrow Robert A - Award D 320,000
2026-01-22 USNA / USANA Health Sciences, Inc. 4 Winssinger Frederic J M - Exercise D 1,058
2026-01-22 USNA / USANA Health Sciences, Inc. 4 Ding Xia M - Exercise D 1,058
2026-01-22 USNA / USANA Health Sciences, Inc. 4 Pelosi Peggie M - Exercise D 1,058
2026-01-22 USNA / USANA Health Sciences, Inc. 4 FULLER GILBERT A M - Exercise D 1,058
2026-01-22 USNA / USANA Health Sciences, Inc. 4 Fleming John Turman M - Exercise D 1,058
2026-01-22 USNA / USANA Health Sciences, Inc. 4 WOOD TIMOTHY E M - Exercise D 1,058
2026-01-22 USNA / USANA Health Sciences, Inc. 4 Nixon J Scott M - Exercise D 1,058
2026-01-22 USNA / USANA Health Sciences, Inc. 4 Pelosi Peggie F - Taxes D 22.51 -669
2026-01-22 USNA / USANA Health Sciences, Inc. 4 WOOD TIMOTHY E F - Taxes D 22.51 -265
2026-01-22 USNA / USANA Health Sciences, Inc. 4 Ding Xia F - Taxes D 22.51 -392
2026-01-16 AKAN / Akanda Corp. 4 HRT FINANCIAL LP S - Sale D 1.29 -7,868
2026-01-15 AKAN / Akanda Corp. 4 HRT FINANCIAL LP P - Purchase D 1.4 29,036
2026-01-15 FTLF / FitLife Brands, Inc. 4 Yakatan Seth P - Purchase D 15.3601 164
2026-01-15 MRMD / MariMed Inc. 4 Pinho Mario M - Exercise D 49,995
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)